e11vk
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 11-K
ANNUAL REPORT
PURSUANT TO SECTION 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
(Mark One):
     
þ   ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    For the fiscal year ended December 31, 2006
OR
     
o   TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    For the transition period from            to           
Commission File Number 000-28782
SPECTRUM PHARMACEUTICALS, INC. 401(K) PLAN
(Full title of the plan)
SPECTRUM PHARMACEUTICALS, INC.
157 Technology Drive
Irvine, California 92618
(Name of issuer of the securities held pursuant to the plan and the address of the issuer’s and plan’s principal executive office)
 
 

 


TABLE OF CONTENTS

Item 1-3
Item 4
SIGNATURES


Table of Contents

REQUIRED INFORMATION
     Item 1-3. The Spectrum Pharmaceuticals, Inc. 401(k) Plan (the “Plan”) is subject to the Employee Retirement Income Security Act of 1974, as amended (“ERISA”). Therefore, in lieu of the requirements of Items 1-3 of Form 11-K, attached are the financial statements of the Plan for the fiscal period ended December 31, 2006, which have been prepared in accordance with the financial reporting requirements of ERISA.
     Item 4. Pursuant to Section 103(c) of ERISA, and the regulations thereunder, the Plan is not required to file audited financial statements, because the Plan has fewer than 100 participants.

 


Table of Contents

STATEMENT OF INCOME AND EXPENSES
Year Ending December 31, 2006
         
INCOME
       
Contribution — Company Matching (co. stock)
  $ 132,231  
Contribution — Participant 401(k)
    261,716  
Investment Earnings
    125,860  
Cash Value of Surrendered Insurance
    0  
Realized Gain From Asset Sale
    0  
Insurance Premium Refunds
    0  
Other Income — Rollovers
    104,907  
Unrealized Appreciation of Assets
    0  
 
     
 
       
Total Income
  $ 624,714  
 
     
EXPENSES
       
Life Insurance Premiums Paid
  0  
Payments to Participants
    53,808  
Bank Charges
    0  
Brokerage Fees
    0  
Administration Expenses Paid By the Trust
    0  
Other Miscellaneous Expenses
    25  
 
     
 
       
Total Expenses
  $ 53,833  
 
     
Income Over Expenses
  570,881  
Assets At The Beginning Of The Plan Year
    673,405  
 
     
Assets At The End Of The Plan Year
  $ 1,244,286  
 
     
PLAN ASSETS AND LIABILITIES
                 
    As of     As of  
    January 1, 2006     December 31, 2006  
ASSETS
               
Cash (Interest Bearing)
  $ 94,819     $ 127,183  
Contribution Receivable — (Co. Match)
    74,910       31,138  
Contribution Receivable — (401-K)
    0       13,595  
Government Securities
    0       0  
Mutual Funds
    474,418       787,983  
Corporate Stocks & Bonds — (Employer Stock)
    0       212,126  
Real Estate and Mortgages
    0       0  
Depreciable Buildings/Property
    0       0  
Participant Loans
    29,258       72,261  
Other Assets
    0       0  
 
           
 
               
Total Assets
  $ 673,405     $ 1,244,286  
 
           
 
               
LIABILITIES
               
Payables
    0       0  
Acquisition Indebtedness
    0       0  
Other Liabilities
    0       0  
 
           
 
               
Total Liabilities
  $ 0     $ 0  
 
           
 
               
NET ASSETS (Assets Less Liabilities)
  $ 673,405     $ 1,244,286  
 
           
SPECTRUM PHARMACEUTICALS, INC. 401(K) PLAN

 


Table of Contents

SIGNATURES
     The Plan. Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons who administer the Plan) have duly caused this annual report to be signed by the undersigned thereunto duly authorized, in the City of Irvine, State of California, on the 16th day of October, 2007.
         
  SPECTRUM PHARMACEUTICALS, INC. 401(K) PLAN
 
 
  By:   Spectrum Pharmaceuticals, Inc.    
         
     
  By:   /s/ Rajesh C. Shrotriya, M.D.    
    Rajesh C. Shrotriya, M.D.    
    Chairman, Chief Executive Officer and President